Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Chemotherapy"
DOI: 10.1080/1120009x.2022.2099693
Abstract: Abstract A number of treatment options have been evaluated in order to prevent the severe progression of COVID-19 pneumonia eventually in patients with increased risk due to comorbidities. Remdesivir for a 3-day outpatient course has… read more here.
Keywords: early day; day; day course; course ... See more keywords